Related Experiment Video

Updated: Jun 20, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Treatment options for nosocomial pneumonia due to MRSA

Michael S Niederman1

  • 1Department of Medicine, Winthrop University Hospital, Mineola, New York, USA. mniederman@winthrop.org

The Journal of Infection
|September 22, 2009
PubMed

Insights

Nosocomial pneumonia caused by MRSA is a growing concern. A de-escalation strategy using antibiotics like linezolid can help reduce mortality and combat antimicrobial resistance.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Antimicrobial Stewardship

Background:

  • Nosocomial pneumonia presents a significant challenge in morbidity and mortality.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging pathogen in nosocomial pneumonia.
  • Antimicrobial resistance is exacerbated by inappropriate empirical antibiotic therapy.

Purpose of the Study:

  • To outline a strategy for managing nosocomial pneumonia, balancing mortality reduction with antimicrobial resistance.
  • To highlight the role of de-escalation therapy in optimizing antibiotic use.
  • To discuss the utility of linezolid in treating ventilator-associated pneumonia caused by MRSA.

Main Methods:

  • Review of current clinical practices and evidence for nosocomial pneumonia management.
  • Analysis of antibiotic de-escalation strategies.
  • Evaluation of linezolid's efficacy against Gram-positive pathogens, including MRSA.

Main Results:

  • A de-escalation approach, starting with broad-spectrum coverage and narrowing based on results, is proposed.
  • Linezolid shows favorable activity against MRSA in ventilator-associated pneumonia.
  • Guidelines recommend linezolid as an alternative to vancomycin for MRSA-documented VAP.

Conclusions:

  • Balancing initial broad-spectrum coverage with de-escalation is crucial for managing nosocomial pneumonia.
  • Linezolid is a valuable option for treating MRSA ventilator-associated pneumonia.
  • Effective antibiotic strategies are essential to reduce mortality and prevent resistance.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...